CCPM is partnering with Regeneron Genetics Center (RGC), a subsidiary of Regeneron Pharmaceuticals, to create a large-scale genomics database. The database will have de-identified genetic and clinical information from biobank participants and will be used to support research and discovery of genetic factors that could inform clinical care.
CCPM is collaborating with BC Platforms to support research and discovery. We are joining their ‘Global Data Partner Network’ (bcrquest.com). Through this partnership, CCPM will share de-identified clinical and genomic data from biobank participants via a secure platform that is used by researchers and pharmaceutical companies around the world.